Semax Peptide 10mg High-Purity Chinese Factory Janoshik Report 99%
37 Inquiries
80714-61-0
Pharmaceutical Grade
99%
shenzhen
ZQ
5mg*10vials
2027-07-01
Semaglutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSEMAX Synthetic is a single, non-glycosylated polypeptide chain containing 7 amino acids, having a molecular mass of 813.92 Dalton and a Molecular formula of C37H51N19O1S.Research & Reference Note
Semax Peptide 10mg High-Purity Chinese Factory Janoshik Report 99% is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
Semax
Other Name:ACTH (4-7), Pro-Gly-Pro-;ACTH (4-7), Pro-Gly-Pro trifluoroacetate salt;L-Methionyl-L-a-glutamyl-L-histidyl-L-phenylalanyl-L-prolylglycyl-L-proline trifluoroacetate salt;Semax;(PRO8,GLY9,PRO10)ACTH-(4-10);SemaxAcetate;L-METHIONYL-L-Α-GLUTAMYL-L-HISTIDYL-L-PHENYLALANYL-L-PROLYLGLYCYL-L-PROLINE;Peptides Semax
CAS No.:80714-61-0
Molecular Formula:C37H51N9O10S
InChIKeys:AFEHBIGDWIGTEH-YNWVLKOQNA-N
Molecular Weight:813.92
EC Number:253-368-1
Color/Form:white to tan
Categories:
Characteristics-
Density:
1.391±0.06 g/cm3(Predicted)
Boiling Point:1335.2±65.0 °C(Predicted)
Water Solubility:Soluble to 2 mg/ml in water
PKA:3.43±0.20(Predicted)
Critical Temperature & Pressure:-20°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide
-
Location:
hangzhou
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Inquiry History37 Inquiries
Country Product Purchase Quantity Date Posted
United States
N-Acetyl Semax Amidate N-Acetyl Semax NA-semax 99% powder 80714-61-0
1 G Dec 24, 2024
Poland
Hot Selling N-Acetyl Semax 99% Petide powder NA-semax CAS 80714-61-0 Semax
300 MG Apr 29, 2026
Spain
Semax CAS 80714-61-0
20 PCS May 7, 2026
Mexico
Hot Selling N-Acetyl Semax NA-semax 99% powder 80714-61-0 Semax
300 G Sep 10, 2023
Australia
Semax
10 MG Feb 9, 2026
United States
N-Acetyl Semax Amidate
1 G Aug 8, 2026
United States
Semax
2 G Jun 10, 2026
United States
semax
30 MG Jun 9, 2026
United States
Semax
1 G Apr 10, 2026
Italy
N-Acetyl Semax
120 MG Mar 11, 2026
United States
Semax
10 PCS Aug 19, 2025
Australia
Semax
50 MG Aug 28, 2024
Reunion Island
N-Acetyl Semax
0.1 G Jan 9, 2024
United States
Semax
100 G Sep 7, 2023
Singapore
Semax
1 G Jun 28, 2026
United Kingdom
Semax
1 G May 27, 2026
Brazil
Semax
1 MT May 19, 2026
United Kingdom
Adamax
1000 MG May 3, 2026
United Kingdom
Semax (Met-Glu-His-Phe-Pro-Gly-Pro)
50 MG Apr 17, 2026
Netherlands
semax peptide raw material
2 G Feb 12, 2026 Post an enquiry for this product
As a prominent player in peptide manufacturing, Hongbai Technology boasts a research and development team comprising seasoned scientists and engineers. This team remains committed to exploration and innovation, focusing on creating peptide products that are safer, more effective, and highly competitive in the market. The company’s core product range spans pharmaceutical-grade, food-grade, and cosmetic-grade peptides, with applications across health maintenance, disease prevention, and beauty skincare. In terms of production, Hongbai Technology employs internationally advanced equipment and technologies. Every stage of the product lifecycle—from raw material selection and processing to finished product packaging—adheres strictly to relevant national standards and regulations, ensuring uncompromising product quality and safety. Additionally, the company has established a comprehensive quality management system and after-sales service network, offering customers all-round, one-stop support. Guided by the corporate philosophy of “Technology Drives Health, Quality Shapes the Future,” Hongbai Technology Co., Ltd. stays true to a people-oriented approach and a path of technological innovation. Beyond prioritizing product quality and innovation, the company actively fulfills its social responsibilities, striving to advance the development and progress of the health industry. Looking ahead, Hongbai Technology Co., Ltd. will continue to deepen its expertise in peptide product research and development, pursue continuous exploration and breakthroughs, and aim to become a global leader in the peptide industry—contributing significantly to human health.
Pls input...
Pls input...